Drug Research
GHO Capital and The Vistria Group Complete Acquisition of Leading CDMO Alcami Corporation
Global Healthcare Opportunities, or GHO Capital Partners LLP ("GHO"), and The Vistria Group today announced that they have completed the acquisition of Alcami Corporation ("Alcami"), a leading pharmaceutical contract development and manufacturing organization (CDMO), from funds affiliated with Madison...
Drug Research
Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo
Duality Biologics, a clinical-stage biotech company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers and autoimmune diseases, announced a license agreement with Adcendo ApS ("Adcendo"), a biotech company focused on the development of breakthrough...
News
Agilent Technologies Inc. Acquires Avida Biomed
Agilent Technologies Inc. has acquired Avida Biomed, an early-stage life sciences company that develops high-performance target enrichment workflows with unique capabilities for clinical researchers utilizing next-generation sequencing (NGS) approaches to study cancer.
The acquisition complements Agilent’s SureSelect portfolio and further augments...
Drug Research
Capsida Biotherapeutics, Prevail Therapeutics Enter Strategic R&D Alliance
Capsida Biotherapeutics Inc. has entered a multi-year strategic collaboration with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Co., to develop genetic medicines for serious diseases. Prevail will leverage Capsida's novel adeno-associated virus (AAV) engineering platform to...
Drug Research
Australia Implements New Measure To Lower Cost of Medicines
Millions of Australians will pay up to 29% less for their Pharmaceutical Benefits Scheme (PBS) prescriptions because the maximum PBS co-payment is going down from $42.50 to $30. The co-payment for general scripts has decreased for the first time...
News
Pharma Bosses See Inflation As The No. 1 Challenge In 2023
According to a survey of executives done by GlobalData Healthcare, the pharmaceutical industry's top concern heading into 2023 is INFLATION.
The study, which was conducted between October 26 and November 23, found that CEOs ranked inflation as the biggest barrier...
News
5 Factors to Consider When Choosing Specialist Clinical Software
Choosing the right specialist clinical software is essential for any healthcare organization. The software will help you manage your patients and their medical records and provide other important features. There are many software options on the market, so deciding...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.